Stay updated on Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A new CABOSUN trial citation was added to Publications with Revision: v3.5.4, and the prior Erratum entry (Revision: v3.5.3) was removed.
    Difference
    0.1%
    Check dated 2026-05-18T12:57:25.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page’s references section now shows an updated CABOSUN trial citation line including the associated erratum entries. The site footer revision/version tag was also updated from v3.5.0 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-27T07:57:36.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. No changes to study content are evident in the screenshot.
    Difference
    0.0%
    Check dated 2026-03-22T09:16:24.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    Footer revision updated to v3.4.3; the previous v3.4.2 label was removed.
    Difference
    0.0%
    Check dated 2026-03-07T20:09:17.000Z thumbnail image
  7. Check
    97 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.4.2, replacing the previous Revision: v3.4.1.
    Difference
    0.0%
    Check dated 2026-02-14T04:38:46.000Z thumbnail image
  8. Check
    104 days ago
    Change Detected
    Summary
    Revision reflects an update from v3.4.0 to v3.4.1 with no visible changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-07T00:49:01.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial page.